Discussion in 'Epidemics (including Covid-19)' started by Sly Saint, Jul 18, 2021 at 11:46 AM.
Excellent news and hope for pwLC.
I hope that ME is not bypassed by these and other researchers
I suspect that as Dr. David Strain is one of the researchers heading this up, there is hopefully a good chance that ME/CFS will be factored in ...
This is quite hopeful.
Seems pretty sketchy.....the living with "recovery program" is a hodgpodge of online advice with the goal grinding through as many patients as possible.
Then either concurrently in a seperate trial or amongst the existing trial will be the drug testing, it's a bit unclear from the wording.
I hope the authors have some airtight methodology planned because there are a lot of moving parts here. Colchicine was another drug at the Stanford clinic a few years back but I guess interest in that died out.
Framing this as "rehabilitation" is especially problematic considering this is what has been tried for the past damn year, entirely wasted expecting it to work so strongly nobody cares that it clearly doesn't. It's literally why research is needed, because of a useless "rehabilitation" paradigm that doesn't even care if there's anything to "rehabilitate", it just plows on and on mindlessly.
We know for a fact this is not relevant. It's an outcome, not a process. Ugh. This is so on brand, "good news" that are actually bad news but it's hard to make it obvious without sounding defeatist except we know how this plays out, it's always the same damn circular failure.
Separate names with a comma.